4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000003
CEO bought 45,000 shares at an average $0.03 ($1,487)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $170 | 20,606,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $170 | 20,611,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +10,000 | $0.03 | $329 | 20,621,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $164 | 20,626,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $165 | 20,631,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $164 | 20,636,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $164 | 20,641,123 | D |
| Collier Alan Brian CEO | 2019-01-14 | Purchase | +5,000 | $0.03 | $163 | 20,646,123 | D |
| Open-market purchases · 45,000 sh · avg $0.03 · $1,487 | |||||||
Loading xslF345X03/primary_doc.xml…